Regulatory milestones in the progress of a drug from conception
to
commercialization: what is the US drug approval process?
The necessity of adhering to stringent specifications of cGLP
/ cGMP. Specific examples of the consequences of non-compliance
will be presented.
History of cGLP / cGMP; FDA regulation of pre-clinical testing?
What are the differences between cGMP and ISO 9000 regulations?
Is cGMP compatible with Total Quality Management?
Role of cGMP for clinical R & D: How are safety, quality
and uniformity of the product ensured? Key data integrity review
points.
Mukund Chorghade
II
2 hours
Organization and management systems:
General provisions and salient features of cGLP / cGMP.
Organization and management structure: regulatory implications;
Involvement of personnel in synthesis, analytical, toxicology,
metabolism and related functions.
Construction of organograms, mission statement and quality goals,
enumeration of services provided by each department.
Requirements for training of staff and documentation of such
training: certification of employees, job competency standards,
job descriptions, continuing education programs and annual refreshers.
Maintenance of staff training records and resumes documenting
qualifications and experience of consultants.
Writing an effective curriculum vitae; designing flow charts
to depict document pedigrees, project management, decision making
and documentation, material flow and disposition; product files;
storage, archiving and retrieval of data.
Study Directors and Quality Control Units: Basic Requirements.
Mukund Chorghade
III
1 hour
Notebooks, logbooks and patents:
storage and archiving of data:
Maintaining a laboratory notebook--Do's and Don'ts: Patent law
and
regulatory constraints; changes in US law for foreign inventors;
electronic signatures, batch records and documents, electronic
submissions.
Raw data analysis and reports; traceability of records; rules
for
retention / archiving; documents needed for a patent application.
Instrument calibration, use, maintenance and repair log books
Veena Chorghade
IV
2 hours
Standard Operating Procedures
and the core elements of cGLP / cGMP:
Writing, approval and dissemination of Standard Operating Procedures;
training of personnel; change control.
Qualification (Installation, operational and performance) and
validation of key equipment, apparatus and computer programs.
Protocols for identity testing of laboratory reagents; quarantine
and QC release; expiration date testing of intermediates and products;
reference standards.
Impurity profiles, stability of drugs, degradants and metabolites,
retaining samples.
The Barr decision; out of specification results; retesting,
resampling
and remixing; deviations; ICH requirements for analytical procedures.
Day
2
Speaker
Session
Topic
Veena Chorghade
I
2 hours
Validation:
Validation: Bulk Pharmaceutical Chemical vs. Dosage Form.
Validation of Solid Dosage Forms: Biobatch relationship, raw
materials, manufacturing directions, equipment, granulation /
mix analysis, in-process controls, test results, investigations
/ product failures.
Sampling size and process control of mixing; scale of scrutiny.
Establishment of limits for cleaning validation.
Control of BPC processes: "Control all steps and validate
critical ones approach"; prospective, concurrent and retrospective
validation.
PhRMA guidelines for production, packing and holding of drug
substances.
Mukund Chorghade
II
2 hours
Technology Transfer Issues:
Writing process and technology transfer reports.
How to transfer bulk pharmaceutical chemical technology from
chemical development to manufacturing.
Necessary documentation and preparation for pre- approval inspections.
Mukund Chorghade
III
2 hours
Outsourcing Issues:
FDA guidelines for inspection of BPCs.
FDA policies on development of enantiomerically pure drugs.
Ancilliarisation: Vendor site validation; strategies for sourcing
of
intermediates.
Day
3
Speaker
Session
Topic
Mukund Chorghade
I
1 hour
Quality Audits and Laboratory
Certification Programs:
Laboratory certification; internal quality audits of laboratory
operations.
Conducting a quality audit: A sample questionnaire / audit
checklist.
Mukund Chorghade
II
1 hour
The FDA Audit:
Dealing with the FDA: Procedures and policies for inspections.
Receiving the FDA inspector: have you written an SOP for this?
Do's and Don'ts: Conducting yourself during an audit; precautions.
The exit interview: FDA 483' s-- Your rights, duties and obligations.
Post-approval cGLP / cGMP compliance.
III
1.5 hours
Miscellaneous:
FDA videos on safety and GMP (Q&A - Discussion time after)
The following sessions
(90 minutes each) are optional
IV
Regulatory requirements affiliated
with filing an IND for New
Chemical / Molecular Entities (NCE's and NME’s); general comments
on pharmacology, toxicology etc.
V
Additional questions and clarifications.
For more information about CTD Quality consulting,
to contact us via email